T835-1697 Screening compound: 3-{[3-(2-methylpropyl)-3H-imidazo[4,5-b]pyridin-2-yl]methyl}-1-(5-methylthiophene-2-carbonyl)pyrrolidine

T835-1697 Screening compound: 3-{[3-(2-methylpropyl)-3H-imidazo[4,5-b]pyridin-2-yl]methyl}-1-(5-methylthiophene-2-carbonyl)pyrrolidine
T835-1697 Screening compound: 3-{[3-(2-methylpropyl)-3H-imidazo[4,5-b]pyridin-2-yl]methyl}-1-(5-methylthiophene-2-carbonyl)pyrrolidine alternative view

Chemical Structure Depiction of ChemDiv screening compound T835-1697
3-{[3-(2-methylpropyl)-3H-imidazo[4,5-b]pyridin-2-yl]methyl}-1-(5-methylthiophene-2-carbonyl)pyrrolidine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T835-1697

Molecular Formula

C21H26N4OS (C21 H26 N4 OS)

Compound Name

3-{[3-(2-methylpropyl)-3H-imidazo[4,5-b]pyridin-2-yl]methyl}-1-(5-methylthiophene-2-carbonyl)pyrrolidine

IUPAC name

3-{[3-(2-methylpropyl)-3H-imidazo[45-b]pyridin-2-yl]methyl}-1-(5-methylthiophene-2-carbonyl)pyrrolidine

SMILES

CC(C)Cn1c(nccc2)c2nc1CC(CC1)CN1C(c1ccc(C)s1)=O

InChI

InChI=1S/C21H26N4OS/c1-14(2)12-25-19(23-17-5-4-9-22-20(17)25)11-16-8-10-24(13-16)21(26)18-7-6-15(3)27-18/h4-7,9,14,16H,8,10-13H2,1-3H3/t16-/m0/s1

InChI Key

GSSGQFXDBCTKFS-INIZCTEOSA-N

MDL Number (MFCD)

MFCD27624181

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

382.53

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

4.542

Distribution Coefficient, logD

4.542

Water Solubility, LogSw

-4.26

Polar Surface Area

39.016

Acid Dissociation Constant (pKa)

21.72

Base Dissociation Constant (pKb)

3.35

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

47.62

T835-1697 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Epigenetics Focused Set (26518 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with T835-1697 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T835-1697?
Check Price and Availability of T835-1697, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T835-1697 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T835-1697
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T835-1697
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T835-1697 available by request